Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity?

British journal of haematology - 1 Mar 2001

Casonato A, Pontara E, Bertomoro A, Sartorello F, Cattini M G, Girolami A

Abstract excerpt

The capability of von Willebrand factor (VWF) to bind platelet glycoprotein Ib (GPIb) and promote platelet plug formation is currently evaluated in vitro using the ristocetin co-factor activity (VWF:RCo) assay. The replacement of this cumbersome and not always reproducible test with the collagen...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation Tests
Share to Collagen
Share to Deamino Arginine Vasopressin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Predictive Value of Tests

Share to Protein Binding

Share to von Willebrand Diseases

Share to von Willebrand Factor

Source

Identifiers

PMID: 11260057
DOI: 10.1046/j.1365-2141.2001.02597.x

Genes

VWF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-11260057-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity?PMID 11260057Read ↗

Performance and clinical utility of a commercial von Willebrand factor collagen binding assay for laboratory diagnosis of von Willebrand disease.Semantic proximity Read ↗

Critical von Willebrand factor A1 domain residues influence type VI collagen binding.Semantic proximity Read ↗

Type 2N von Willebrand disease: Characterization and diagnostic difficulties.Semantic proximity Read ↗

Evaluation of an heterogeneous group of patients with von Willebrand disease using an assay alternative to ristocetin induced platelet agglutination.Semantic proximity Read ↗

Large experience with a factor VIII binding assay of plasma von Willebrand factor using commercial reagents.Semantic proximity Read ↗

Advances in the diagnosis and treatment of Von Willebrand disease.Semantic proximity Read ↗

Diagnosis and classification of von Willebrand disease: a review of the differential utility of various functional von Willebrand factor assays.Semantic proximity Read ↗

Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.